COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 2959: Articles 29581-29590  | Next

Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR
Wikramaratna, P., Paton, R. S., Ghafari, M., Lourenco, J.
10.1101/2020.04.05.20053355 — Posted: 2020-04-07
Estimating number of cases and spread of Coronavirus disease 2019 (COVID-19) in the United Kingdom using critical care admissions, February to March 2020
Jit, M., Jombart, T., Nightingale, E., Endo, A., Abbott, S., Edmunds, W. J.
10.1101/2020.04.05.20054528 — Posted: 2020-04-07
Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity
Karin, O., Bar-On, Y. M., Milo, T., Katzir, I., Mayo, A., Korem, Y., Dudovich, B., Zehavi, A. J., Davidovich, N., Milo, R., Alon, U.
10.1101/2020.04.04.20053579 — Posted: 2020-04-07
A mechanistic population balance model to evaluate the impact of interventions on infectious disease outbreaks: Case for COVID19
Rodriguez, J., Acuna, J. M., Uratani, J. M., Paton, M.
10.1101/2020.04.04.20053017 — Posted: 2020-04-07
Estimate of the development of the epidemic reproduction number Rt from Coronavirus SARS-CoV-2 case data and implications for political measures based on prognostics
Khailaie, S., Mitra, T., Bandyopadhyay, A., Schips, M., Mascheroni, P., Vanella, P., Lange, B., Binder, S., Meyer-Hermann, M.
10.1101/2020.04.04.20053637 — Posted: 2020-04-07 Discussion: Onsite
Association of COVID-19 Infections in San Francisco in Early March 2020 with Travel to New York and Europe
Gu, W., Reyes, K., Hsu, E., Miller, S., Chiu, C. Y.
10.1101/2020.04.04.20053629 — Posted: 2020-04-07 Discussion: Onsite
Search for trends of Covid-19 infection in India, China, Denmark, Brazil, France. Germany and the USA on the basis of power law scaling
BHATTACHARYA, S., ISLAM, M. M., DE, A.
10.1101/2020.04.03.20052878 — Posted: 2020-04-07
Validation of reported risk factors for disease classification and prognosis in COVID-19: a descriptive and retrospective study
Tan, L., Kang, X., Ji, X., Wang, Q., li, Y., Wang, Q., Miao, H.
10.1101/2020.04.05.20053769 — Posted: 2020-04-07
Explaining the Bomb-Like Dynamics of COVID-19 with Modeling and the Implications for Policy
Lin, G., Strauss, A. T., Pinz, M., Martinez, D. A., Tseng, K. K., Schueller, E., Gatalo, O., Yang, Y., Levin, S. A., Klein, E. Y., For the CDC MInD-Healthcare Program
10.1101/2020.04.05.20054338 — Posted: 2020-04-07
Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19
Tian, S., Zhu, X., Sun, X., Wang, J., Zhou, Q., Wang, C., Chen, L., Xu, J.
10.1101/2020.04.04.20053280 — Posted: 2020-04-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).